Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 501–550 of 1,704 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07581314	Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)	not yet recruiting	Phase 1 / Phase 2	76	Telomir Pharmaceuticals, Inc.INDUSTRY	0	Jun 23, 2026	clinicaltrials
NCT07662031	Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer	not yet recruiting	Phase 2	25	Washington University School of MedicineOTHER	1	Jun 23, 2026	clinicaltrials